Global point of care
Webinars
How can POCT benefit healthcare professionals in diagnosing
and managing diabetes and comorbidities?
Published July 20, 2022
Summary
In this webinar a panel of experts from around the world - USA, Japan and Switzerland – discuss how they use point of care testing for the management of their patients with diabetes and comorbidities.
This webinar will be chaired by Dr. Vivian Fonseca, an endocrinology, diabetes & metabolism specialist in Metairie, Louisiana, USA. He is current Chief, Endocrinology at the Tulane University School of Medicine.
Dr. Fonseca starts the webinar with his talk about the benefits of HbA1c POC testing may provide.
Dr. Yasuhiro Iijima is diabetologist and director at the Fujiyasu Clinic and works also at the Department of Diabetes Metabolism and Endocrinology al Tokyo Medical University, Japan. Dr. Iijima presents on his experience with POC lipid testing.
PD Dr. Andreas Kistler is Department Chief of Internal Medicine at the Kantonsspital Frauenfeld in Zurich, Switzerland. Dr. Kistler shares which impact the availability of ACR testing at the point-of-care has on the identification and management of kidney disease.
Learning Objectives
- Understand the value of POC testing in Diabetes
- Understand the importance of albuminuria in practice
- Understand how Lipid testing at the POC can impact treatment of patients
- Case studies
Presenter Biography
Dr. Vivian Fonseca
(USA)
Chair
The Value of point-of-care testing in Diabetes
PD DR. ANDREAS DAVID KISTLER
(Switzerland)
Speaker
Relevance of Determining Aluminum in Urine in The Practice
DR. YASUHIRO IIJIMA
(Japan)
Speaker
Immediate lipid testing with POC is effective and attractive for the treatment and education of outpatients.
Who Should Watch
Endocrinologists, Mental Health Practitioners, Psychiatrists, Cardiologists, Primary Care Physicians, Nephrologists, Healthcare professionals, Clinicians, POC coordinators, Physicians, General practitioners
